Ingela Danielsson

Ingela Danielsson, MD, Ph.D., MBA, is the Chief Medical Officer at the Gene Vector Institute and has over 30 years of experience in medical affairs and research. Ingela has led numerous Phase I–III clinical trials, published works in peer-reviewed journals, and served as Medical Director at Cyberonics Inc. and Medical Director/Chief Medical Officer at the Texas Department of Aging and Disability Services. With a strong background in neurology, neurophysiology, and healthcare quality management, Ingela is board certified and holds an Executive MBA with a focus on finance. Currently, Ingela is also pursuing advanced fellowships in neurophysiology and administration at prestigious institutions.